Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Cellular ontogeny and MLL breakpoint site influence the capacity of MLL-edited CD34+ hematopoietic cells to initiate and recapitulate infant patients' features in pro-B-cell acute lymphoblastic leukemia (B-ALL). We provide key insights into the leukemogenic determinants of MLL-AF4+ infant B-ALL.

More information Original publication

DOI

10.1182/blood.2023020858

Type

Journal article

Publication Date

2023-11-16T00:00:00+00:00

Volume

142

Pages

1752 - 1756

Total pages

4

Keywords

Infant, Humans, Gene Editing, Myeloid-Lymphoid Leukemia Protein, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Hematopoietic Stem Cells, Oncogene Proteins, Fusion